When the president revived an effort to ban drug rebates, most lobbyists assumed HHS would have to restart rulemaking since the department had withdrawn a rebate-ban proposed rule last year, but HHS is ignoring that withdrawal, and a former adviser to the Trump White House said the proposed rule was not officially terminated. At issue is a final rebate-ban rule that the Office of Management and Budget began reviewing Friday (Nov. 13). In the summer of 2019, the White...